Ausbil Investment Management Ltd Has $1.06 Million Stock Position in Chemed Co. (NYSE:CHE)

Ausbil Investment Management Ltd increased its holdings in shares of Chemed Co. (NYSE:CHE) by 105.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,980 shares of the company’s stock after buying an additional 1,016 shares during the quarter. Ausbil Investment Management Ltd’s holdings in Chemed were worth $1,059,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. HighTower Advisors LLC increased its stake in Chemed by 78.0% during the 3rd quarter. HighTower Advisors LLC now owns 3,730 shares of the company’s stock worth $2,246,000 after purchasing an additional 1,634 shares in the last quarter. XTX Topco Ltd raised its position in Chemed by 111.5% in the 3rd quarter. XTX Topco Ltd now owns 2,843 shares of the company’s stock valued at $1,709,000 after buying an additional 1,499 shares during the last quarter. Geode Capital Management LLC lifted its stake in Chemed by 4.9% in the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock valued at $201,820,000 after acquiring an additional 15,791 shares in the last quarter. Signal Advisors Wealth LLC boosted its position in Chemed by 60.7% during the 4th quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company’s stock worth $2,647,000 after acquiring an additional 1,886 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Chemed by 8.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 122,788 shares of the company’s stock worth $73,792,000 after acquiring an additional 9,178 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Royal Bank of Canada reduced their target price on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a report on Tuesday, November 5th. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th.

Chemed Trading Up 0.1 %

Shares of CHE opened at $562.09 on Friday. The company has a market cap of $8.46 billion, a price-to-earnings ratio of 28.40, a PEG ratio of 2.18 and a beta of 0.47. The company’s fifty day simple moving average is $544.78 and its 200 day simple moving average is $564.03. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $654.62.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The business had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. Chemed’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the firm earned $5.32 EPS. As a group, research analysts forecast that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Monday, November 18th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, November 18th. This represents a $2.00 annualized dividend and a dividend yield of 0.36%. Chemed’s dividend payout ratio is presently 10.11%.

Insider Activity

In other Chemed news, EVP Spencer S. Lee sold 732 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the transaction, the executive vice president now directly owns 18,287 shares of the company’s stock, valued at $10,526,362.94. This trade represents a 3.85 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the transaction, the chief executive officer now owns 101,735 shares of the company’s stock, valued at approximately $58,270,755.95. This represents a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is owned by company insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.